Dr Poulami ChaudhuriFounder

India - ND

I bring over a decade of experience in lipid nanoparticle-based delivery, peptide-based delivery, and molecular biology, with a focus on advancing genomic medicines. I completed my PhD and MSc at King’s College London, where my research focused on non-viral delivery systems for therapeutic applications, including the development of peptide-based vectors for siRNA delivery in cancer treatments.

During my postdoctoral work at TCS Innovation Labs, I explored 3D genome architecture and epigenetics in human cells, which laid the foundation for my leadership in developing the EPIC-Cure™ drug design platform at Helex. As Lead Scientist at TCS Innovation Labs, I led critical research on genetic diseases like Duchenne Muscular Dystrophy (DMD), which contributed to the development of several patents.

At Helex, I have been driving the development of innovative lipid nanoparticle (LNP) and drug design platforms, securing numerous patents for novel lipids, LNPs, and gene-editing technologies. I’m deeply committed to advancing cutting-edge delivery platforms that tackle high-burden diseases and transform the landscape of genomic medicines by making them accessible to patients worldwide.